Bill · S
S. 545 (119th)
Combating Illicit Xylazine Act
Original
Introduced
12 February 2025
Last action
15 April 2026 · Reported
Status
Placed on Senate Legislative Calendar under General Orders. Calendar No. 372.
Sponsors
Sen. Cortez Masto, Catherine [D-NV], Sen. Grassley, Chuck [R-IA], Sen. Hassan, Margaret Wood [D-NH], Sen. Gillibrand, Kirsten E. [D-NY], Sen. Hyde-Smith, Cindy [R-MS], Sen. Cantwell, Maria [D-WA], Sen. Scott, Rick [R-FL], Sen. Shaheen, Jeanne [D-NH], Sen. Klobuchar, Amy [D-MN], Sen. Britt, Katie Boyd [R-AL], Sen. Capito, Shelley Moore [R-WV], Sen. Young, Todd [R-IN], Sen. Kelly, Mark [D-AZ], Sen. Kaine, Tim [D-VA], Sen. Risch, James E. [R-ID], Sen. Rosen, Jacky [D-NV], Sen. Blumenthal, Richard [D-CT], Sen. Luján, Ben Ray [D-NM], Sen. Wicker, Roger F. [R-MS], Sen. Gallego, Ruben [D-AZ], Sen. Tillis, Thomas [R-NC], Sen. Fetterman, John [D-PA], Sen. Bennet, Michael F. [D-CO], Sen. Lummis, Cynthia M. [R-WY], Sen. Budd, Ted [R-NC], Sen. King, Angus S., Jr. [I-ME], Sen. Justice, James C. [R-WV], Sen. Crapo, Mike [R-ID], Sen. McCormick, David [R-PA], Sen. Lankford, James [R-OK], Sen. Moody, Ashley [R-FL], Sen. Blackburn, Marsha [R-TN], Sen. Cornyn, John [R-TX], Sen. Durbin, Richard J. [D-IL], Sen. Cruz, Ted [R-TX], Sen. Merkley, Jeff [D-OR]
Subjects
Healthcare, Crime and Law Enforcement
Source updated
26 August 2026
Healthcare · Crime and Law Enforcement
Summary
Combating Illicit Xylazine Act This bill regulates xylazine under the Controlled Substances Act (CSA). Xylazine, also known as tranq , is a nonopioid sedative and pain reliever that is approved for use in animals. Recently, the Drug Enforcement Administration (DEA) has reported an increase in trafficking of fentanyl mixed with xylazine. This bill adds xylazine, including its salts, isomers, and salts of isomers, to schedule III of the CSA. Schedule III controlled substances, including anabolic steroids, buprenorphine, and ketamine, have less potential for abuse than a schedule I or II substance, have a currently accepted medical use, and have low or moderate risk of dependence if abused. Under the bill, manufacturing, distributing, or dispensing xylazine, or possessing with intent to manufacture, distribute, or dispense xylazine for illicit use is subject to criminal penalties under the CSA. The bill also requires xylazine transactions to be tracked in the drug reporting system maintained by the DEA. The bill exempts from registration under the CSA persons and entities that possess xylazine (1) lawfully dispensed by a veterinarian or pharmacy and (2) for an animal or for use in certain animal-control or wildlife programs. The bill also exempts xylazine manufacturers from the CSA's physical security requirements. Finally, the bill requires the DEA, in coordination with the Department of Health and Human Services (HHS), to provide Congress with a report on how the agencies previously determined whether xylazine should be a controlled substance, including the full text of HHS's recommendations to the DEA for scheduling xylazine.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
12 February 2025
Introduced
Read twice and referred to the Committee on the Judiciary.
Source: IntroReferral
12 February 2025
Introduced
Introduced in Senate
Source: IntroReferral
26 March 2026
Reported
Committee on the Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably.
Source: Committee
15 April 2026
Calendars
Placed on Senate Legislative Calendar under General Orders. Calendar No. 372.
Source: Calendars
15 April 2026
Reported
Committee on the Judiciary. Reported by Senator Grassley with an amendment in the nature of a substitute. Without written report.
Source: Committee
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Reported to Senate
Reported to Senate · EN · 15 April 2026
Reported to Senate
summary · EN · 15 April 2026
Introduced in Senate
Introduced in Senate · EN · 12 February 2025
Sponsors
- Sen. Cortez Masto, Catherine [D-NV] · D · Sponsor
- Sen. Grassley, Chuck [R-IA] · R · Sponsor
- Sen. Hassan, Margaret Wood [D-NH] · D · Sponsor
- Sen. Gillibrand, Kirsten E. [D-NY] · D · Sponsor
- Sen. Hyde-Smith, Cindy [R-MS] · R · Sponsor
- Sen. Cantwell, Maria [D-WA] · D · Sponsor
- Sen. Scott, Rick [R-FL] · R · Sponsor
- Sen. Shaheen, Jeanne [D-NH] · D · Sponsor
- Sen. Klobuchar, Amy [D-MN] · D · Sponsor
- Sen. Britt, Katie Boyd [R-AL] · R · Sponsor
- Sen. Capito, Shelley Moore [R-WV] · R · Sponsor
- Sen. Young, Todd [R-IN] · R · Sponsor
- Sen. Kelly, Mark [D-AZ] · D · Sponsor
- Sen. Kaine, Tim [D-VA] · D · Sponsor
- Sen. Risch, James E. [R-ID] · R · Sponsor
- Sen. Rosen, Jacky [D-NV] · D · Sponsor
- Sen. Blumenthal, Richard [D-CT] · D · Sponsor
- Sen. Luján, Ben Ray [D-NM] · D · Sponsor
- Sen. Wicker, Roger F. [R-MS] · R · Sponsor
- Sen. Gallego, Ruben [D-AZ] · D · Cosponsor
- Sen. Tillis, Thomas [R-NC] · R · Cosponsor
- Sen. Fetterman, John [D-PA] · D · Cosponsor
- Sen. Bennet, Michael F. [D-CO] · D · Cosponsor
- Sen. Lummis, Cynthia M. [R-WY] · R · Cosponsor
- Sen. Budd, Ted [R-NC] · R · Cosponsor
- Sen. King, Angus S., Jr. [I-ME] · I · Cosponsor
- Sen. Justice, James C. [R-WV] · R · Cosponsor
- Sen. Crapo, Mike [R-ID] · R · Cosponsor
- Sen. McCormick, David [R-PA] · R · Cosponsor
- Sen. Lankford, James [R-OK] · R · Cosponsor
- Sen. Moody, Ashley [R-FL] · R · Cosponsor
- Sen. Blackburn, Marsha [R-TN] · R · Cosponsor
- Sen. Cornyn, John [R-TX] · R · Cosponsor
- Sen. Durbin, Richard J. [D-IL] · D · Cosponsor
- Sen. Cruz, Ted [R-TX] · R · Cosponsor
- Sen. Merkley, Jeff [D-OR] · D · Cosponsor
- · ssju00 · Standing
Related records
- related to → Combating Illicit Xylazine Act
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/119th-congress/senate-bill/545
- Open data entity: https://api.congress.gov/v3/bill/119/s/545
- us · 119-s-545 · source updated 26 August 2026